These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3608625)

  • 21. Antibacterial action of amphipathic derivatives of isoniazid against the Mycobacterium avium complex.
    Rastogi N; Moreau B; Capmau ML; Goh KS; David HL
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jun; 268(4):456-62. PubMed ID: 3213317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex.
    Heifets LB; Iseman MD; Lindholm-Levy PJ
    Drugs Exp Clin Res; 1987; 13(9):529-38. PubMed ID: 3428133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Etest for rapid susceptibility testing of Mycobacterium avium to clarithromycin.
    Lebrun L; Onody C; Vincent V; Nordmann P
    J Antimicrob Chemother; 1996 May; 37(5):999-1003. PubMed ID: 8737150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of in vitro antimycobacterial activities of ansamycin and rifampicin].
    Tsukamura M; Mizuno S; Toyama H; Ichiyama S
    Kekkaku; 1986 Oct; 61(10):497-503. PubMed ID: 3100853
    [No Abstract]   [Full Text] [Related]  

  • 28. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory MA
    Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacteriostatic effects of sulfadimethoxine and kitasamycin on Mycobacterium avium-M. intracellulare complex].
    Tsukamura M
    Kekkaku; 1983 Apr; 58(4):247-50. PubMed ID: 6632486
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin.
    Czinn S; Carr H; Aronoff S
    Antimicrob Agents Chemother; 1986 Aug; 30(2):328-9. PubMed ID: 3767346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sensitivity tests of mycobacteria to INH, SM, EMB and RMP in a semi-liquid serum-sauton-agar (author's transl)].
    Neubert R
    Z Erkr Atmungsorgane; 1976; 144(1):63-8. PubMed ID: 823718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro comparative study of RU 28965 against organisms from oral and vaginal flora.
    Romeo MA; Lo Bue AM; Chisari G; Gismondo MR; Nicoletti G
    G Batteriol Virol Immunol; 1986; 79(1-6):16-24. PubMed ID: 3500081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
    Marone P; Bono L; Carretto E; Barbarini D; Telecco S
    J Chemother; 1997 Aug; 9(4):247-50. PubMed ID: 9269603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In-vitro susceptibility of Mycobacterium avium complex to isoniazid and ethionamide].
    Tsukamura M; Yamori S
    Kekkaku; 1990 Mar; 65(3):243-7. PubMed ID: 2352411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex.
    Tsukamura M
    Am Rev Respir Dis; 1988 Jan; 137(1):144-8. PubMed ID: 3337455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
    Kobaisy M; Abramowski Z; Lermer L; Saxena G; Hancock RE; Towers GH; Doxsee D; Stokes RW
    J Nat Prod; 1997 Nov; 60(11):1210-3. PubMed ID: 9392889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation of minimal inhibitory concentration values of antituberculosis agents against Mycobacterium avium complex strains with incubation period].
    Tsukamura M; Ichiyama S
    Kekkaku; 1988 Feb; 63(2):107-10. PubMed ID: 3373933
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro sensitivity of Mycobacterium avium and Mycobacterium xenopi to erythromycin, roxithromycin and doxycycline].
    Maugein J; Fourche J; Mormede M; Pellegrin JL
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):565-7. PubMed ID: 2797881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium].
    Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K
    Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Rao M; Sood R; Malhotra S; Fatma T; Upadhyay DJ; Rattan A
    J Chemother; 2006 Apr; 18(2):144-50. PubMed ID: 16736882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.